HAL Allergy Group products

Our allergoid SCIT product is available for most prevalent allergens such as grasses, trees and mites. It is a modern form of therapy involving specific modified allergens. The advantage of this form of treatment is enhanced safety (by means of significantly reduced allergenicity), combined with a high level of efficacy. The benefit is a simple and patient-friendly immunotherapy.

HAL Allergy offers allergen drops that can be administered by applying a few drops under the tongue (sublingual immunotherapy). Sublingual products are manufactured from standardized allergen extracts formulated in glycerol. Glycerol improves the dosing of the product by enhancing the stickiness in the mouth, and is a stabilizer of the allergen extracts.

Our wasp and bee venom SCIT product is an immunotherapy designed for people with an allergy to wasp or bee stings. Its effect is brought about by administering increasing amounts of the venom.

Our sublingual (SLIT) product is a high-dose treatment with proven long-term efficacy. With an administration of a few drops under the tongue, the patient can carry out the treatment at home and it allows for an individually tailored treatment. Sublingual immunotherapy is available for a wide range of respiratory allergens. The therapy is specifically designed to target the allergen or combination of allergens to which the patient is sensitive for easy and convenient home administration.

Subcutaneous immunotherapy (SCIT) available for major respiratory and venom allergens. Our subcutaneous (SCIT) allergoid product is designed for a faster, simpler and more effective immunotherapy to improve the patient’s convenience for the treatment of a wide range of allergic symptoms, from allergic conjunctivitis and allergic rhinitis to allergic asthma.